461
Views
4
CrossRef citations to date
0
Altmetric
Review

New pharmacotherapy for heart failure with reduced ejection fraction

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 405-414 | Received 24 Apr 2020, Accepted 15 Jun 2020, Published online: 30 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Adam Ioannou, Sofia Metaxa, Steny Simon, Amit K. J. Mandal & Constantinos G. Missouris. (2020) Letter to the Editor - New Pharmacotherapy for Heart Failure with Reduced Ejection Fraction. Expert Review of Cardiovascular Therapy 18:9, pages 651-652.
Read now

Articles from other publishers (3)

Daisuke Usuda, Toshihiro Higashikawa, Yuta Hotchi, Kenki Usami, Shintaro Shimozawa, Shungo Tokunaga, Ippei Osugi, Risa Katou, Sakurako Ito, Toshihiko Yoshizawa, Suguru Asako, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Jiro Oba, Tomohisa Nomura & Manabu Sugita. (2021) Angiotensin receptor blocker neprilysin inhibitors. World Journal of Cardiology 13:8, pages 326-340.
Crossref
Daisuke Usuda, Toshihiro Higashikawa, Yuta Hotchi, Kenki Usami, Shintaro Shimozawa, Shungo Tokunaga, Ippei Osugi, Risa Katou, Sakurako Ito, Toshihiko Yoshizawa, Suguru Asako, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Jiro Oba, Tomohisa Nomura & Manabu Sugita. (2021) Angiotensin receptor blocker neprilysin inhibitors. World Journal of Cardiology 13:8, pages 325-339.
Crossref
Sara Sotirakos. (2021) Evaluation of dapagliflozin in the treatment of heart failure. Future Cardiology 17:3, pages 415-425.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.